ICAM1 and myocardial infarction: Different from our findings, a small randomized study including 18 patients with acute myocardial infarction assessed the effect of TMZ on plasma ICAM-1 levels, which identified that the plasma ICAM-1 level of the TMZ group was elevated for the first 24 h but decreased in the next two days [42].